Literature DB >> 14738653

Testing for toxoplasmosis in pregnancy: a study of the routines in primary antenatal care.

Anne Eskild1, Gunn Fallås Dahl, Kjetil K Melby, Britt-Ingjerd Nesheim.   

Abstract

OBJECTIVES: The question of benefit of screening for antibodies against Toxoplasma gondii in pregnancy to prevent impairment in the infant has not been settled. Despite this, it is believed that such testing is common. The aim of this study was to describe the test routines and to identify factors associated with testing in primary antenatal care.
SETTING: Ulleval University Hospital, Oslo, Norway.
METHODS: All women who gave birth at Ulleval University Hospital, Oslo, Norway, in May 2000 were included. The number of antibody tests during pregnancy was obtained from the patient registry at the department of microbiology at the same hospital.
RESULTS: 81% (361/446) had been tested for antibodies against Toxoplasma gondii during pregnancy. Women attending primary antenatal care at a specialist in obstetrics and gynaecology were most likely to be tested. Among women with no signs of prior toxoplasmosis, 35% (110/317) were tested only once. DISCUSSION: The majority of pregnant women are being tested for toxoplasmosis even though such testing has no documented preventive effect and has not been recommended.

Entities:  

Mesh:

Year:  2003        PMID: 14738653     DOI: 10.1258/096914103771773258

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  2 in total

1.  Implementation of Screening for Toxoplasma gondii Infection in Pregnancy.

Authors:  Massimo De Paschale; Carlo Agrappi; Maria Teresa Manco; Teresa Cerulli; Pierangelo Clerici
Journal:  J Clin Med Res       Date:  2010-05-19

2.  Persistent Low Toxoplasma IgG Avidity Is Common in Pregnancy: Experience from Antenatal Testing in Norway.

Authors:  Gry Findal; Babill Stray-Pedersen; Ellen K Holter; Tone Berge; Pål A Jenum
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.